At Nano Biotherapeutics, our mission is to treat acute and chronic inflammation and tissue injury in the heart and lungs using albumin nanoparticle mediated drug delivery.
Our nano drug platform is based on albumin, a natural protein, and our nanoparticle can entrap small hydophobic drugs. We load it with an anti-inflammatory drug to target activated neutrophils, which accumulates at the site of injury. Then, the released drug suppresses inflammation.